Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun:154:155873.
doi: 10.1016/j.cyto.2022.155873. Epub 2022 Apr 5.

SARS-CoV-2 triggering autoimmune diseases

Affiliations
Review

SARS-CoV-2 triggering autoimmune diseases

Leila Mobasheri et al. Cytokine. 2022 Jun.

Abstract

Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as "cytokine storm," and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4+ and CD8+ T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.

Keywords: Autoimmune disease; Autoimmunity; Covid-19; Cytokine; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
The SARS-CoV-2 proliferates by binding to ACE-2 receptor on the surface of host epithelial cell. Intracellular signaling pathways are activated and produce inflammatory cytokines such as TNF-α, IFN-β, IL-6, IL-1β, IL-17, and IL-18 that may cause autoimmunity via systemic inflammation. APCs process the antigens and present them to TCD4+ cells. Activated TCD4+ cells have a role in inflammatory cytokine secretion, MQ activation, and antibody formation. Antibody against the viral antigen can recognize host tissue antigens that cause autoimmunity. Also, TCD8+ cells can detect viral antigens via TCR-MHC I and cause apoptosis in virus-infected and uninfected cells mainly via perforin-granzyme and Fas and its ligand. This procedure is named bystander activation and causes autoimmunity. The apoptotic bodies which contain self-antigens are presented to autoreactive T cells and cause autoimmunity. Given that autoimmunity is driven by recognition of self-antigen and CD8 T-cell exhaustion dependent on chronic antigen stimulation, T-cell exhaustion could facilitate the retention of antigen-specific T cells in the repertoire under chronic stimulation. Also, the reduction of T-reg by the SARS-CoV-2 reduces self-tolerance and leads to autoimmunity.

Similar articles

Cited by

References

    1. Tu H., Tu S., Gao S., Shao A., Sheng J. Current epidemiological and clinical features of COVID-19; a global perspective from China. J. Infect. 2020 - PMC - PubMed
    1. Ge H., Wang X., Yuan X., Xiao G., Wang C., Deng T., Yuan Q., Xiao X. The epidemiology and clinical information about COVID-19. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39(6):1011–1019. - PMC - PubMed
    1. Sarda S.R., Tekale S.U., Kótai L., Domb A.J., Pawar R.P. COVID-19: A global pandemic. Eur. Chem. Bull. 2020;9(8):266–272.
    1. Raheem R., Alsayed R., Yousif E., Hairunisa N. Coronavirus new variants: the mutations cause and the effect on the treatment and vaccination: Coronavirus new Variants: effect and treatments. Baghdad J. Biochem. Appl. Biol. Sci. 2021;2(02):70–78.
    1. Jain V., Yuan J.-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int. J. Public Health. 2020;65(5):533–546. - PMC - PubMed